yuchang li | Chinese Medicine | Best Researcher Award

Mr. yuchang li | Chinese Medicine | Best Researcher Award

Shanxi University of Chinese Medicine | China

AUTHOR PROFILE

ORCID ID

🎓 EARLY ACADEMIC PURSUITS

Yu-chang Li is currently a student at Shanxi University of Chinese Medicine, enrolled in the Third Clinical College of Clinical Medicine, specializing in Traditional Chinese and Western Medicine. From an early stage in his academic journey, he has demonstrated a strong passion for integrating traditional Chinese medicine (TCM) with modern medical approaches. His commitment to research and academic excellence has been recognized through numerous awards and publications.

🏆 PROFESSIONAL ENDEAVORS

Yu-chang Li has made significant contributions to medical research, particularly in the field of oncology alternative medicine. His work bridges the gap between traditional Chinese medicine and Western medical practices, exploring innovative therapeutic approaches to combat life-threatening diseases.

His achievements include:
Winner of multiple prestigious awards, including:

  • National Silver Award at the 10th National College Students Basic Medical Innovation Research and Experimental Design Forum
  • Provincial Silver Award
  • Provincial Bronze Award

Published two SCI-indexed research papers, demonstrating expertise in oncology and alternative medicine.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CHINESE MEDICINE

Yu-chang Li’s research is centered on the role of Chinese herbal medicine in oncology, with a particular focus on the immunomodulatory effects of Astragalus membranaceus (Huangqi) and other herbal formulations.

🔹 Astragalus Injection and Osteosarcoma
One of his landmark studies, Astragalus Injection Inhibits the Growth of Osteosarcoma by Activating Cytotoxic T Lymphocyte and Targeting CTSL, investigates the use of Huangqi Injection (HQI) in treating osteosarcoma. His research highlights the immunomodulatory potential of HQI, demonstrating that its active component, Cycloastragenol (CG), enhances immune response and targets CTSL, leading to tumor suppression.

🔹 Shenqi Granules and Cerebral Ischemia-Reperfusion Injury
In another study, Shenqi Granules Enhance Recovery from Cerebral Ischemia-Reperfusion Injury by Modulating Tryptophan and Tyrosine Metabolism and Activating NFE2L2/NRF2, he explores the neuroprotective effects of Shenqi granules. His findings contribute to stroke rehabilitation research, emphasizing the potential of herbal formulations in neurological recovery.

His research provides scientific validation for traditional Chinese medicine (TCM) therapies, paving the way for their integration into modern medical treatments.

🌍 IMPACT AND INFLUENCE

Yu-chang Li’s research has had a profound impact on both oncology and alternative medicine by:
📌 Advancing integrative medicine through scientific validation of herbal treatments.
📌 Contributing to cancer immunotherapy using TCM-based approaches.
📌 Providing new perspectives on the treatment of osteosarcoma and stroke recovery.
📌 Inspiring future researchers to explore synergistic applications of Chinese and Western medicine.

📖 ACADEMIC CITATIONS AND RECOGNITION

As a young scholar, Yu-chang Li’s publications have gained recognition in the scientific community, contributing valuable insights to the fields of Chinese medicine and oncology. His work is frequently cited by researchers investigating herbal immunotherapy, oncology treatments, and neuroprotection strategies.

🔮 LEGACY AND FUTURE CONTRIBUTIONS

Yu-chang Li is poised to become a leading figure in integrative medicine, focusing on oncology and alternative therapies. His future contributions may include:
✨ Developing new herbal formulations for cancer treatment.
✨ Conducting clinical trials to further validate TCM therapies.
✨ Bridging the gap between traditional and modern medicine.
✨ Expanding the global acceptance of TCM in cancer care.

His research and innovations will undoubtedly shape the future of medicine, providing safe, effective, and scientifically backed treatments that integrate the wisdom of traditional Chinese medicine with modern scientific advancements.

🌍CONCLUSION 

Yu-chang Li is a rising scholar in integrative medicine, dedicated to advancing the scientific understanding of Traditional Chinese Medicine (TCM) and its applications in oncology and neurological disorders. His research on Astragalus Injection in osteosarcoma and Shenqi granules in stroke recovery showcases the therapeutic potential of herbal medicine, reinforcing the importance of evidence-based alternative treatments.

 

📊🔬NOTABLE PUBLICATION:
  • Title: Shenqi granules enhance recovery from cerebral ischemia-reperfusion injury by modulating tryptophan and tyrosine metabolism and activating NFE2L2/NRF2.
    Authors: Liu HX, Yang MK, Li YC, Liu CX, Li GP, Meng XL, Pei K, Wen SY
    Journal: International Journal of Phytotherapy and Phytopharmacology
    Year: 2025

 

  • Title: Astragalus injection inhibits the growth of osteosarcoma by activating cytotoxic T lymphocyte and targeting CTSL.
    Authors: Liu HX, Li YC, Su RB, Liu CX, Wen SY.
    Journal: Journal of Ethnopharmacology
    Year: 2025

Prof. Hongsheng Liu | Pharmaco-Oncology | Best Researcher Award

Prof. Hongsheng Liu | Pharmaco-Oncology | Best Researcher Award

Liaoning University | China

Author Profile

Scopus

🌟 Professor Hongsheng Liu: A Pioneer in Microbiology and Bioinformatics

Professor, School of Pharmaceutical Sciences, Liaoning University, China

🔬 Academic and Professional Background

Professor Hongsheng Liu obtained a Master’s degree in Microbiology from China Agricultural University in 1991 and later pursued a Ph.D. in Microbiology and Bioinformatics at Gifu University School of Medicine, Japan, in 2004. Over the years, he has expanded his expertise by serving as a visiting scholar at prestigious institutions such as Wuhan University, the University of Hong Kong, Harvard Medical School, and Hebrew University of Jerusalem. His career reflects a deep commitment to advancing the fields of microbiology, bioinformatics, and pharmaceutical sciences.

💡 Research and Innovations

Professor Liu has completed an impressive 74 research projects and authored over 100 journal articles (SCI, Scopus, etc.), accumulating a citation index of 2721. His work spans diverse areas, including the discovery of the novel microorganism Paenibacillus liaoningensis sp. nov. and the investigation of influenza virus interactions. His contributions to computational biology include the development of several predictive algorithms and online platforms like CarcinoPred-EL and LiverToxPred-EL. Additionally, Professor Liu holds 37 patents, has published 4 books, and has led 7 industry consultancy projects.

📚 Published Works and Collaborations

Professor Liu’s collaborative research includes partnerships with renowned institutions such as the University of Toledo, Harvard Medical School, and Eberhard Karl University of Tübingen. He has also served as a guest editor for Frontiers in Microbiology (2017-2018). His dedication to both basic and applied research continues to push the boundaries of pharmaceutical sciences.

👥 Professional Memberships

He is an active member of the Chinese Society for Microbiology (CSM) and the Chinese Chemical Society (CCS).

🌍 Areas of Research

Professor Liu specializes in computer-aided drug design and the simulation of biomacromolecule interactions, with a focus on studying lncRNAs and disease relationships, and designing stable recombinant proteins using engineered bacteria.

🔔 Conclusion

Professor Hongsheng Liu stands as a distinguished leader in microbiology and bioinformatics, contributing significantly to drug design, biomolecular simulation, and microbial discovery. His broad academic collaborations, cutting-edge innovations, and vast research output underscore his influence in the scientific community. Through his extensive work on predictive algorithms, microbial databases, and recombinant protein design, he has made impactful advancements in pharmaceutical sciences. With over 100 journal publications, 37 patents, and numerous prestigious collaborations, Professor Liu’s dedication to advancing scientific knowledge and improving human health is truly commendable.

📊🔬NOTABLE PUBLICATION:

    • Article Title: Ensemble multiclassification model for aquatic toxicity of organic compounds
      Authors: Li, X., Liu, G., Wang, Z., Liu, H., Ai, H.
      Journal: Aquatic Toxicology
      Year: 2023

     

    • Article Title: Construction of an oxidative stress-related lncRNAs signature to predict prognosis and the immune response in gastric cancer
      Authors: Zhang, H., Feng, H., Yu, T., Ma, L., Liu, H.
      Journal: Scientific Reports
      Year: 2023

     

    • Article Title: CBIL-VHPLI: a model for predicting viral-host protein-lncRNA interactions based on machine learning and transfer learning
      Authors: Zhang, M., Zhang, L., Liu, T., Zhao, J., Liu, H.
      Journal: Scientific Reports
      Year: 2024

     

    • Article Title: Construction of highly active and stable recombinant nattokinase by engineered bacteria and computational design
      Authors: Wang, L., Meng, J., Yu, X., Zhang, L., Liu, H.
      Journal: Archives of Biochemistry and Biophysics
      Year: 2024

     

    • Article Title: Effects of dietary supplementation of gallic tannic acid on growth, intestinal digestive enzymes activity, innate immunity, morphology, and microbial composition of Cyprinus carpio
      Authors: Feng, H., Zhao, S., Ma, X., Liu, Z., Liu, H.
      Journal: Aquaculture International
      Year: 2024

Assoc Prof Dr. Haruto Nishida | Breast Cancer Immunity | Best Researcher Award

Assoc Prof Dr. Haruto Nishida | Breast Cancer Immunity | Best Researcher Award

Faculty of Medicine, Oita University | Japan

Author Profile 

Scopus

🧬 Dr. Haruto Nishida, M.D., Ph.D. – Associate Professor of Diagnostic Pathology

Haruto Nishida, M.D., Ph.D., is an Associate Professor at the Department of Diagnostic Pathology at Oita University Hospital, Japan, where he has served in this role since April 2021. Dr. Nishida has a profound expertise in pathology, with a particular focus on diagnostic pathology, cytology, and molecular pathology.

🎓 Education and Early Career

Dr. Nishida earned his Medical Degree from the Faculty of Medicine at Oita University in 2009. He furthered his academic journey by obtaining a Ph.D. from the same institution in 2015, specializing in pathology. His post-graduate training includes a residency in General Medicine at Oita Medical Hospital and a fellowship in Diagnostic Pathology at Oita University.

🩺 Professional Experience

Dr. Nishida’s career at Oita University has been marked by progressive roles. Starting as an Assistant Professor in 2012, he was promoted to Lecturer in 2019 and then to Associate Professor in 2020. He continued in this role when he transitioned to Oita University Hospital in 2021, where he currently leads efforts in diagnostic pathology.

🏅 Board Certifications and Licensure

Dr. Nishida holds multiple prestigious board certifications, including the Japanese Board Certification in Pathology, Autopsy, Cytology, and Molecular Pathology. He earned his National Board of Medicine license in 2009, showcasing his dedication to the field.

🌍 Professional Affiliations

Dr. Nishida is an active member of several professional organizations, both in Japan and internationally. He is involved with the Japanese Society of Pathology, Japanese Society of Clinical Cytology, Japan Dermatopathology Society, and the Bone and Soft Tissue Tumor Club of Japan. Additionally, he is a member of the United States and Canadian Academy of Pathology (USCAP) and the International Academy of Cytology.

Dr. Nishida’s contributions to the field of pathology, combined with his ongoing research and teaching, make him a distinguished figure in diagnostic pathology.

🚀 Conclusion

In summary, Dr. Haruto Nishida is a highly accomplished pathologist whose extensive expertise and dedication to diagnostic pathology have significantly contributed to the field. His career, marked by a progression of academic and clinical roles at Oita University, is underpinned by his strong educational background and numerous board certifications. As an active member of both national and international professional organizations, Dr. Nishida continues to impact the field through his research, teaching, and clinical work. His ongoing commitment to excellence in pathology makes him a respected leader in the medical community.

 

📊🔬NOTABLE PUBLICATION:

 

  • SOX10-Internal Tandem Duplications and PLAG1 or HMGA2 Fusions Segregate Eccrine-Type and Apocrine-Type Cutaneous Mixed Tumors
    Authors: Macagno, N., Kervarrec, T., Thanguturi, S., De la Fouchardière, A., Battistella, M.
    Journal: Modern Pathology
    Year: 2024

 

  • Recurrent Cardiac Tamponade Following Coronavirus Disease 2019 mRNA Vaccination: A Case Report
    Authors: Kaimori, R., Nishida, H., Yahiro, T., Iwami, T., Daa, T.
  • Journal: Cardiovascular Pathology
    Year: 2024

 

  • Lipid Droplet Detection in Histopathological Images Using Reinforcement Learning
    Authors: Harada, Y., Nishida, H., Matsuura, K.
    Journal: Biotechnology and Biotechnological Equipment
    Year: 2024

 

  • Right Atrial Cardiac Myxoma with Malignant Transformation to Undifferentiated Sarcoma: A Case Report
    Authors: Kaimori, R., Nishida, H., Oyama, Y., Kawamura, K., Daa, T.
    Journal: Cardiovascular Pathology
    Year: 2024

 

  • The Relationship Between Tumor Immunity and the cGAS–STING Pathway in Breast Cancer: An Immunohistochemical Study
    Authors: Nishida, H., Ohara, N., Kato, A., Kawamura, K., Daa, T.
    Journal: Experimental and Molecular Pathology
    Year: 2024

Assoc Prof Dr. Elcin Aydin | Endometrium Cancer | Best Researcher Award

Assoc Prof Dr. Elcin Aydin | Endometrium Cancer | Best Researcher Award

University of Health Sciences, Izmir | Turkey

AUTHOR PROFILE

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

  • Assoc Prof Dr. Elçin Aydın’s academic journey began with a strong foundation in medical sciences. She pursued her education with a focus on radiology, demonstrating a keen interest in the diagnostic and therapeutic applications of imaging technologies. Her early academic pursuits laid the groundwork for her specialization in abdominal and genitourinary radiology.

PROFESSIONAL ENDEAVORS

  • Dr. Aydın is currently affiliated with the University of Health Sciences in Izmir, Turkey, and works at Izmir City Hospital. Her professional endeavors have been marked by a commitment to clinical excellence and academic rigor. She has been an active member of prestigious organizations such as the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), the European Congress of Radiology (ECR), and the European Society of Urogenital Radiology (ESUR).

CONTRIBUTIONS AND RESEARCH FOCUS

  • Dr. Aydın has made significant contributions to the field of radiology through her research and clinical work. She has published 14 original articles in SCI-EXP indexed journals and authored 4 case studies, highlighting her expertise in abdominal and genitourinary radiology. Her research focuses on the diagnostic accuracy and clinical applications of imaging techniques in these areas, aiming to improve patient outcomes through advanced radiological practices.

IMPACT AND INFLUENCE

  • Through her scholarly publications and clinical practice, Dr. Aydın has had a considerable impact on the field of radiology. Her work is frequently cited by peers, reflecting the influence of her research on contemporary radiological practices. Her involvement in ESGAR, ECR, and ESUR underscores her influence within the radiological community, where she contributes to the advancement of knowledge and practice standards.

ACADEMIC CITATIONS

  • Dr. Aydın’s research has garnered significant academic attention, with numerous citations in prominent radiological journals. Her studies on abdominal and genitourinary radiology are referenced by other researchers and clinicians, indicating the high regard in which her work is held. This academic recognition is a testament to the quality and relevance of her research contributions.

LEGACY AND FUTURE CONTRIBUTIONS ON ENDOMETRIUM CANCER

  • Dr. Aydın’s legacy in the field of radiology is characterized by her dedication to advancing medical imaging and improving patient care. Looking ahead, she is poised to continue her impactful research and clinical work, with a focus on innovative imaging techniques and their applications in abdominal and genitourinary radiology. Her future contributions are expected to further enhance the understanding and practice of radiology, benefiting both the medical community and patients.

OTHER IMPORTANT TOPICS

TEACHING AND MENTORSHIP

  • In addition to her research and clinical responsibilities, Dr. Aydın is deeply committed to teaching and mentoring the next generation of radiologists. Her role at the University of Health Sciences allows her to shape the education and training of medical students and residents, ensuring the continued growth and development of the field.

COLLABORATIVE PROJECTS

  • Dr. Aydın actively engages in collaborative projects with other institutions and researchers. These collaborations enable the sharing of knowledge and expertise, fostering innovation and improving radiological practices globally. Her collaborative efforts have resulted in several joint publications and research initiatives.

PROFESSIONAL DEVELOPMENT

  • Continuous professional development is a cornerstone of Dr. Aydın’s career. She regularly participates in international conferences, workshops, and training programs to stay abreast of the latest advancements in radiology. This commitment to lifelong learning ensures that she remains at the forefront of her field, providing the highest standard of care to her patients.

 

📊🔬Notable Publication:

Extrapulmonary Tuberculosis: An Old but Resurgent Problem

  • Authors: Baykan, A.H., Sayiner, H.S., Aydin, E., Inan, I., Erturk, S.M.
    Journal: Insights into Imaging
  • Year: 2022

 

Quantitative Analysis of the Olfactory System in COVID-19: An MR Imaging Study

  • Authors: Altunisik, E., Baykan, A.H., Sahin, S., Aydin, E., Erturk, S.M.
    Journal: American Journal of Neuroradiology
  • Year: 2021

 

Primary Breast Tuberculosis: Imaging Findings of a Rare Disease

  • Authors: Baykan, A.H., Sayiner, H.S., Inan, I., Aydin, E., Erturk, S.M.
    Journal: Insights into Imaging
  • Year: 2021

 

Reliability of Real-Time Sonoelastography in the Diagnosis of Supraspinatus Tendinopathy

  • Authors: Aydın, E., Söylev, G.Ö., Muratlı, S.K., Tekindal, M.A., Ağıldere, M.
    Journal: Ultrasound Quarterly
  • Year: 2021

 

Optical Coherence Tomography-Angiography Findings of Prediabetic Patients

  • Authors: Emre, S., Altin, C., Ulusoy, M.O., Aydin, E.
    Journal: Oman Journal of Ophthalmology
  • Year: 2024

Prof. Elina Genina | Tumor Model | Best Researcher Award

Prof. Elina Genina | Tumor Model | Best Researcher Award

Saratov State University | Russia

Author Profile

Scopus

Orcid id

Google Scholar

📚 Biography: Prof. Elina A. Genina

  • 🎓 Education:

    • Saratov State University, Saratov, Russia
      • MS in Radiophysics and Electronics, 1993
      • PhD in Biophysics, 2002
      • Dr.Sc. in Biophysics, 2017
  • 🏢 Professional Experience:

    • Full Professor, Chair of Optics and Biophotonics, Saratov State University (SSU), since 2018
    • Senior Researcher, Interdisciplinary Laboratory on Biophotonics, Tomsk State University, 2014–2018
    • Associate Professor, Chair of Optics and Biophotonics, SSU, 2003–2018
    • Assistant Professor, Chair of Optics, SSU, 2002–2003
    • Engineer, Chair of Optics, SSU, 2000–2002
    • PhD Student, Chair of Optics, SSU, 1996–2001
    • Engineer, Institute of Chemistry, SSU, 1993–1997
  • 🌟 Honors and Awards:

    • George Soros PhD student awards, 1999 and 2000
    • Post-Doctoral Fellowship Award, U.S. Civilian Research and Development Foundation for the Independent States of the Former Soviet Union (CRDF), 2003
    • Welcome Trust Award, 2005
    • Nano Research Top Papers Award, 2016
  • 📚 Teaching Experience:

    • Courses on Fundamentals of Photobiology, Photomedicine, Tissue Optics, Measurement Methods in Biology and Medicine, and more
  • 📝 Research Interests:

    • Biological and medical physics, biophotonics, biomedical optics, nanobiophotonics, OCT, optical and laser measurements, photodynamic/photothermal therapy
  • 📃 Selected Papers:

    • Published numerous papers and reviews in peer-reviewed journals such as J. Biophotonics, J. Biomedical Optics, and others
  • 🎙️ Professional Activities:

    • Member of editorial boards and reviewer for various scientific journals
    • Member of international conference committees including Saratov Fall Meeting
  • 📘 Book Editor:

    • Edited “Handbook of tissue optical clearing: new prospects in optical imaging,” CRC Press, 2022
  • 🏅 Special Issues:

    • Guest editor and contributor to special issues in journals and proceedings on biophotonics technologies

📊🔬Notable Publication:

Photothermal and photodynamic therapy of tumors with plasmonic nanoparticles: challenges and prospects

Authors: Alla B Bucharskaya, Nikolai G Khlebtsov, Boris N Khlebtsov, Galina N Maslyakova, Nikita A Navolokin, Vadim D Genin, Elina A Genina, Valery V Tuchin

Journal: Materials

Year: 2022

 

Rapid ultrasound optical clearing of human light and dark skin

  • Authors: Elina A Genina, Yury I Surkov, Isabella A Serebryakova, Alexey N Bashkatov, Valery V Tuchin, Vladimir P Zharov
  • Journal: IEEE Transactions on Medical Imaging
  • Year: 2020

 

Optical clearing of tissues: issues of antimicrobial phototherapy and drug delivery

  • Authors: Valery V Tuchin, Elina A Genina, Elena S Tuchina, Anna V Svetlakova, Yulia I Svenskaya
  • Journal: Advanced Drug Delivery Reviews
  • Year: 2021

 

Optimized skin optical clearing for optical coherence tomography monitoring of encapsulated drug delivery through the hair follicles

  • Authors: Sergey M Zaytsev, Yulia I Svenskaya, Ekaterina V Lengert, Georgy S Terentyuk, Alexey N Bashkatov, Valery V Tuchin, Elina A Genina
  • Journal: Journal of Biophotonics
  • Year: 2020

 

Glycerol effects on optical, weight and geometrical properties of skin tissue

  • Authors: Vadim D Genin, Elina A Genina, Valery V Tuchin, Alexey N Bashkatov
  • Journal: Journal of Innovative Optical Health Sciences
  • Year: 2021